These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 20861488)

  • 21. Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects.
    Rooryck C; Morice-Picard F; Elçioglu NH; Lacombe D; Taieb A; Arveiler B
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):583-7. PubMed ID: 18821858
    [No Abstract]   [Full Text] [Related]  

  • 22. Mutational Analysis of TYR, OCA2, SLC45A2, and TYRP1 Genes Identifies Novel and Reported Mutations in Chinese Families with Oculocutaneous Albinism.
    Xu B; Chen X; Li H
    Altern Ther Health Med; 2023 Oct; 29(7):278-283. PubMed ID: 37471664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of candidate gene mutations associated with Indian familial oculocutaneous and ocular albinism.
    Renugadevi K; Sil AK; Perumalsamy V; Sundaresan P
    Mol Vis; 2010 Aug; 16():1514-24. PubMed ID: 20806075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of oculocutaneous albinism: a compact review.
    Kamaraj B; Purohit R
    Biomed Res Int; 2014; 2014():905472. PubMed ID: 25093188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation Analysis of 63 Northwest Chinese Probands with Oculocutaneous Albinism.
    Chuan Z; Yan Y; Hao S; Zhang Q; Zhou B; Feng X; Wang X; Liu F; Zheng L; Cao Z; Ma X
    Curr Eye Res; 2021 Jan; 46(1):140-143. PubMed ID: 32552135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical albinism score, presence of nystagmus and optic nerves defects are correlated with visual outcome in patients with oculocutaneous albinism.
    Dumitrescu AV; Tran J; Pfeifer W; Bhattarai SV; Kemerley A; Dunn TV; Wang K; Scheetz TE; Drack A
    Ophthalmic Genet; 2021 Oct; 42(5):539-552. PubMed ID: 34251969
    [No Abstract]   [Full Text] [Related]  

  • 27. Identifying genetic defects in oculocutaneous albinism patients of West Bengal, Eastern India.
    Dutta T; Ganguly K; Saha A; Sil A; Ray K; Sengupta M
    Mol Biol Rep; 2024 Jul; 51(1):818. PubMed ID: 39014059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type.
    Hutton SM; Spritz RA
    J Invest Dermatol; 2008 Oct; 128(10):2442-50. PubMed ID: 18463683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Five Novel Variants in Chinese Oculocutaneous Albinism by Targeted Next-Generation Sequencing.
    Qiu B; Ma T; Peng C; Zheng X; Yang J
    Genet Test Mol Biomarkers; 2018 Apr; 22(4):252-258. PubMed ID: 29437493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico analysis of miRNA-mediated gene regulation in OCA and OA genes.
    Kamaraj B; Gopalakrishnan C; Purohit R
    Cell Biochem Biophys; 2014 Dec; 70(3):1923-32. PubMed ID: 25060099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4.
    Rundshagen U; Zühlke C; Opitz S; Schwinger E; Käsmann-Kellner B
    Hum Mutat; 2004 Feb; 23(2):106-110. PubMed ID: 14722913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biallelic mutations in L-dopachrome tautomerase (DCT) cause infantile nystagmus and oculocutaneous albinism.
    Volk AE; Hedergott A; Preising M; Rading S; Fricke J; Herkenrath P; Nürnberg P; Altmüller J; von Ameln S; Lorenz B; Neugebauer A; Karsak M; Kubisch C
    Hum Genet; 2021 Aug; 140(8):1157-1168. PubMed ID: 33959807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel TYR and TYRP1 mutations in oculocutaneous albinism.
    Forshew T; Khaliq S; Tee L; Smith U; Johnson CA; Mehdi SQ; Maher ER
    Clin Genet; 2005 Aug; 68(2):182-4. PubMed ID: 15996218
    [No Abstract]   [Full Text] [Related]  

  • 34. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive study of oculocutaneous albinism type 1 reveals three previously unidentified alleles on the TYR gene.
    Lin YY; Wei AH; He X; Zhou ZY; Lian S; Zhu W
    Eur J Dermatol; 2014; 24(2):168-73. PubMed ID: 24721949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analyses of Chinese patients with digenic oculocutaneous albinism.
    Wei AH; Yang XM; Lian S; Li W
    Chin Med J (Engl); 2013 Jan; 126(2):226-30. PubMed ID: 23324268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
    Newton JM; Cohen-Barak O; Hagiwara N; Gardner JM; Davisson MT; King RA; Brilliant MH
    Am J Hum Genet; 2001 Nov; 69(5):981-8. PubMed ID: 11574907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oculocutaneous albinism type 1A: a case report.
    Karaman A
    Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of TYR mutations in patients with oculocutaneous albinism.
    Sun W; Shen Y; Shan S; Han L; Li Y; Zhou Z; Zhong Z; Chen J
    Mol Med Rep; 2018 Jun; 17(6):8409-8413. PubMed ID: 29658579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
    Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S
    BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.